Diagnosing melanoma January 18, 2017 By John Jesitus Newer tools to help diagnose challenging lesions include combined immunohistochemical stains and a growing array of genetic tests, one of which has shown the potential to gauge metastatic risk. Motivating teens not to tan, on teens’ terms January 04, 2017 By Lisette Hilton You might be surprised about what researchers have uncovered about why teens tan. Having a better understanding of their motives, could help you help them. Responding to melanoma’s growing threat January 04, 2017 By Lisette Hilton Melanoma’s burden is increasing and the rising rates cannot simply be attributed to increased disease detection, according to a research letter published last month in JAMA Dermatology. World-wide skin cancer epidemiology November 30, 2016 By Ilya Petrou M.D The incidence of melanoma appears to be on the rise except for that observed in the younger population, underscoring a positive trend and hope for the fight against skin cancer. Research looks at melanocyte role in tumor formation November 08, 2016 By Bob Kronemyer While melanocytes have strong mechanisms for repair, those in individuals with certain risk factors may carry impaired repair responses. Studies have begun to examine melanocytes in patients at risk for developing melanoma with the hope of developing strategies for preventing deadly tumors. Clinical acumen key for identifying pediatric melanoma Experts discuss diagnosis and management of pediatric melanoma, including the latest developments in genetic tools and indications for sentinel lymph node biopsy. Clinical stage at diagnosis could affect melanoma survival September 07, 2016 By Paul Nicolaus NYU researchers suggest a difference in the tumor progression of stage IV melanoma patients based on the initial clinical stage at original diagnosis. Best practices for treating severe sun damage August 12, 2016 By Lisette Hilton The goal of treatment for severely sun-damaged patients’ lesions is field therapy, which not only treats what dermatologists see, but also subclinical disease. New evidence supports combination therapy for metastatic melanoma August 09, 2016 By Louise Gagnon Evidence-based data about molecular features is evolving to support the use of combination therapy as an option for treating metastatic melanoma. New target could predict melanoma August 08, 2016 By Lisette Hilton New information could eventually help identify a high-risk population before they get cancer — even prevent skin cancer’s onset.